Histatin-1 is an endogenous ligand of the sigma-2 receptor

被引:9
|
作者
Son, Kyung-No [1 ]
Lee, Hyun [2 ]
Shah, Dhara [1 ]
Kalmodia, Sushma [1 ]
Miller, Ryan Cree [3 ]
Ali, Marwan [1 ]
Balasubramaniam, Arun [1 ]
Cologna, Stephanie M. [4 ]
Kong, Hyunjoon [3 ]
Shukla, Deepak [1 ]
Aakalu, Vinay Kumar [1 ]
机构
[1] Univ Illinois, Dept Ophthalmol & Visual Sci, 1855 W Taylor St,MC 648,Suite 3-158, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Pharmaceut Sci & Biophys Core, Res Resources Ctr, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Chem & Biomol Engn, Champaign, IL USA
[4] Univ Illinois, Dept Chem, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
antimicrobial peptide; histatin-1; MAC30; migration; sigma-2; receptor; TMEM97; wound healing; PROTEIN; MAC30; EXPRESSION; MIGRATION; IDENTIFICATION; PROLIFERATION; ADHESION; NPC1; RNA;
D O I
10.1111/febs.16108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Sigma-2 receptor (S2R) (a.k.a TMEM97) is an important endoplasmic reticular protein involved in cancer, cholesterol processing, cell migration, and neurodegenerative diseases, including Niemann-Pick Type C. While several S2R pharmacologic agents have been discovered, its recent (2017) cloning has limited biological investigation, and no endogenous ligands of the S2R are known. Histatins are a family of endogenous antimicrobial peptides that have numerous important effects in multiple biological systems, including antifungal, antibacterial, cancer pathogenesis, immunomodulation, and wound healing. Histatin-1 (Hst1) has important roles in epithelial wound healing and cell migration, and is the primary wound healing agent in saliva. Little is understood about the downstream machinery that underpins the effects of histatins, and no mammalian receptor is known to date. In this study, we show, using biophysical methods and functional assays, that Hst1 is an endogenous ligand for S2R and that S2R is a mammalian receptor for Hst1.
引用
收藏
页码:6815 / 6827
页数:13
相关论文
共 50 条
  • [41] Sigma-2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy
    Huang, Yun-Sheng
    Lu, He-Lin
    Zhang, Lang-Jun
    Wu, Zongwen
    MEDICINAL RESEARCH REVIEWS, 2014, 34 (03) : 532 - 566
  • [42] Selective sigma-2 receptor ligands derived from tetrahydroisoquinolone
    Xie, Jesse J.
    Shih, Jonathan
    Mesangeau, Christophe
    Seminerio, Michael
    Xu, Yan-Tong
    Matsumoto, Rae R.
    McCurdy, Christopher R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [43] Sigma-2 Receptor as Potential Indicator of Stem Cell Differentiation
    Haller, Jodi L.
    Panyutin, Irina
    Chaudhry, Aneeka
    Zeng, Chenbo
    Mach, Robert H.
    Frank, Joseph A.
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (03) : 325 - 335
  • [44] Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands
    Wu, Zong-Wen
    Song, Shu-Yong
    Li, Li
    Lu, He-Lin
    Lieberman, Brian
    Huang, Yun-Sheng
    Mach, Robert H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (07) : 1463 - 1471
  • [45] The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine
    John R Hornick
    Jinbin Xu
    Suwanna Vangveravong
    Zhude Tu
    Jonathan B Mitchem
    Dirk Spitzer
    Peter Goedegebuure
    Robert H Mach
    William G Hawkins
    Molecular Cancer, 9
  • [46] Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
    John R Hornick
    Suwanna Vangveravong
    Dirk Spitzer
    Carmen Abate
    Francesco Berardi
    Peter Goedegebuure
    Robert H Mach
    William G Hawkins
    Journal of Experimental & Clinical Cancer Research, 31
  • [47] Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
    Wilson, Lisa L.
    Alleyne, Amy R.
    Eans, Shainnel O.
    Cirino, Thomas J.
    Stacy, Heather M.
    Mottinelli, Marco
    Intagliata, Sebastiano
    McCurdy, Christopher R.
    McLaughlin, Jay P.
    MOLECULES, 2022, 27 (11):
  • [48] The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine
    Hornick, John R.
    Xu, Jinbin
    Vangveravong, Suwanna
    Tu, Zhude
    Mitchem, Jonathan B.
    Spitzer, Dirk
    Goedegebuure, Peter
    Mach, Robert H.
    Hawkins, William G.
    MOLECULAR CANCER, 2010, 9
  • [49] Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
    Hornick, John R.
    Vangveravong, Suwanna
    Spitzer, Dirk
    Abate, Carmen
    Berardi, Francesco
    Goedegebuure, Peter
    Mach, Robert H.
    Hawkins, William G.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [50] MEDI 292-Development of the first predictive pharmacophore models for sigma-1 and sigma-2 receptor antagonists
    De Jesus, Melvin
    Correa, Wildeliz
    Stepanenko, Viatcheslav
    Guzman, Irisbel
    de la Cruz, Wilanet
    Ortiz, Margarita
    Ortiz, Lymaris
    Vazquez, Cindybeth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 864 - 864